The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New leadership moves, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Leadership Trends
See who's moving and how much in your market
No credit card required Weekly executive digest
Corrixr Therapeutics Appoints Hilary M. Malone As Chief Executive Officer
PRIVATEJun 03, 2026•14 days ago
Position
Chief Executive Officer
Company
CorriXR Therapeutics
Hilary M. Malone, Ph.D.
NewarkBiotechnology
Description
Corrixr Therapeutics has appointed Hilary M. Malone, Ph.D. as its new Chief Executive Officer to lead the company's growth and accelerate its lead program, CXR101, toward clinical trials
Company Information
Company
CorriXR Therapeutics
Location
550 S College Ave, Suite 107
Newark, Delaware, United States
About
CorriXR Therapeutics is on the clinical frontier of gene editing as a transformative pre-clinical stage biotechnology company with a ground-breaking in vivo gene editing therapeutic platform technology. CorriXR Therapeutics advances CRISPR/Cas gene editing technology to develop new genetic medicines directed against drug-resistant solid tumors.
NewarkBiotechnology